Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: Exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis

Respiration

Volumn 89, Issue 3, 2015, Pages 181-189

  Burtin, Chris ^a   Hebestreit, Helge ^b  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Bronchiectasis; Cystic fibrosis; Exercise; Non cystic fibrosis bronchiectasis; Physical activity; Rehabilitation

Indexed keywords

BRONCHIECTASIS; BRONCHOCONSTRICTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CYSTIC FIBROSIS; EXERCISE; FITNESS; FRACTURE; HEART ARRHYTHMIA; HEMOPTYSIS; HUMAN; HYPOXEMIA; LIFESTYLE; LUNG FUNCTION; MUSCLE WEAKNESS; NON CYSTIC FIBROSIS BRONCHIECTASIS; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; RISK; RISK BENEFIT ANALYSIS; SAFETY; SPRAIN; CHRONIC DISEASE; COMPLICATION; EXERCISE TOLERANCE; KINESIOTHERAPY; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RESPIRATION DISORDERS;

BRONCHIECTASIS; CHRONIC DISEASE; CYSTIC FIBROSIS; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; MOTOR ACTIVITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS;

EID: 84925234854     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000375170     Document Type: Review

References (99)

1. Barker AF: Bronchiectasis. N Engl J Med 2002; 346: 1383-1393.
2. Morrissey BM: Pathogenesis of bronchiectasis. Clin Chest Med 2007; 28: 289-296.
3. King PT, Holdsworth SR, Freezer NJ, et al: Outcome in adult bronchiectasis. COPD 2005; 2: 27-34.
4. O'Donnell AE: Bronchiectasis. Chest 2008; 134: 815-823.
5. Riordan JR, Rommens JM, Kerem B, et al: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
6. O'Sullivan BP, Freedman SD: Cystic fibrosis. Lancet 2009; 373: 1891-1904.
7. Britto MT, Kotagal UR, Hornung RW, et al: Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002; 121: 64-72.
8. de BK, Vandemheen KL, Tullis E, et al: Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax 2011; 66: 680-685.
9. Goeminne P, Dupont L: Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J 2010; 86: 493-501.
10. Radtke T, Stevens D, Benden C, et al: Clinical exercise testing in children and adolescents with cystic fibrosis. Pediatr Phys Ther 2009; 21: 275-281.
11. Klijn PH, Terheggen-Lagro SW, van der Ent CK, et al: Anaerobic exercise in pediatric cystic fibrosis. Pediatr Pulmonol 2003; 36: 223-229.
12. de Meer K, Gulmans VA, van Der Laag J: Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999; 159: 748-754.
13. Troosters T, Langer D, Vrijsen B, et al: Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009; 33: 99-106.
14. Cabrera ME, Lough MD, Doeshuk CF, et al: Anaerobic performance assessed by the Wingate Test in patients with cystic fibrosis. Pediatr Exerc Sci 1993; 5: 78-87.
15. Gale NS, Bolton CE, Duckers JM, et al: Systemic comorbidities in bronchiectasis. Chron Respir Dis 2012; 9: 231-238.
16. Moorcroft AJ, Dodd ME, Webb AK: Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997; 52: 291-293.
17. Nixon PA, Orenstein DM, Kelsey SF, et al: The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327: 1785-1788.
18. Dodd JD, Barry SC, Barry RB, et al: Bone mineral density in cystic fibrosis: benefit of exercise capacity. J Clin Densitom 2008; 11: 537-542.
19. Hebestreit H, Schmid K, Kieser S, et al: Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulm Med 2014; 14: 26.
20. Bradley J, McAlister O, Elborn S: Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001; 17: 712-715.
21. Alison JA, Regnis JA, Donnelly PM, et al: End-expiratory lung volume during arm and leg exercise in normal subjects and patients with cystic fibrosis. Am J Respir Crit Care Med 1998; 158: 1450-1458.
22. Perpati G, Nanas S, Pouliou E, et al: Resting respiratory variables and exercise capacity in adult patients with cystic fibrosis. Respir Med 2010; 104: 1444-1449.
23. Klijn PH, van der Net J, Kimpen JL, et al: Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest 2003; 124: 2215-2219.
24. Dodd JD, Barry SC, Barry RB, et al: Thin-section CT in patients with cystic fibrosis: correlation with peak exercise capacity and body mass index. Radiology 2006; 240: 236-245.
25. Hebestreit H, Kieser S, Rudiger S, et al: Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006; 28: 734-739.
26. Dodd JD, Barry SC, Daly LE, et al: Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibros 2005; 4: 101-105.
27. Selvadurai HC, McKay KO, Blimkie CJ, et al: The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 762-765.
28. Pianosi P, Pelech A: Stroke volume during exercise in cystic fibrosis. Am J Respir Crit Care Med 1996; 153: 1105-1109.
29. Koelling TM, Dec GW, Ginns LC, et al: Left ventricular diastolic function in patients with advanced cystic fibrosis. Chest 2003; 123: 1488-1494.
30. Moorcroft AJ, Dodd ME, Morris J, et al: Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis. Eur Respir J 2005; 25: 1050-1056.
31. Pinet C, Cassart M, Scillia P, et al: Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 989-994.
32. Hussey J, Gormley J, Leen G, et al: Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros 2002; 1: 116-121.
33. Sahlberg ME, Svantesson U, Thomas EM, et al: Muscular strength and function in patients with cystic fibrosis. Chest 2005; 127: 1587-1592.
34. Selvadurai HC, Allen J, Sachinwalla T, et al: Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 1476-1480.
35. Wells GD, Wilkes DL, Schneiderman JE, et al: Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 2011; 69: 40-45.
36. Gupta A, Eastham KM, Wrightson N, et al: Hypomagnesaemia in cystic fibrosis patients referred for lung transplant assessment. J Cyst Fibros 2007; 6: 360-362.
37. Ionescu AA, Nixon LS, Luzio S, et al: Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 495-500.
38. Wood LG, Fitzgerald DA, Gibson PG, et al: Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001; 20(suppl 2):157-165.
39. Barry SC, Gallagher CG: Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol (1985) 2003; 95: 1379-1384.
40. Lamhonwah AM, Bear CE, Huan LJ, et al: Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 2010; 67: 802-808.
41. Divangahi M, Balghi H, Danialou G, et al: Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009; 5:e1000586.
42. Wieboldt J, Atallah L, Kelly JL, et al: Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis. J Cyst Fibros 2012; 11: 209-215.
43. Burtin C, Van RH, Vrijsen B, et al: Impact of exacerbations of cystic fibrosis on muscle strength. Respir Res 2013; 14: 46.
44. Olveira G, Olveira C, Gaspar I, et al: Fat-free mass depletion and inflammation in patients with bronchiectasis. J Acad Nutr Diet 2012; 112: 1999-2006.
45. Ionescu AA, Chatham K, Davies CA, et al: Inspiratory muscle function and body composition in cystic fibrosis. Am J Respir Crit Care Med 1998; 158: 1271-1276.
46. Selvadurai HC, Blimkie CJ, Cooper PJ, et al: Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004; 89: 928-933.
47. Schneiderman-Walker J, Wilkes DL, Strug L, et al: Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr 2005; 147: 321-326.
48. Garber CE, Blissmer B, Deschenes MR, et al: American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43: 1334-1359.
49. Tejero GS, Giraldez Sanchez MA, Cejudo P, et al: Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest 2011; 140: 475-481.
50. Schneiderman JE, Wilkes DL, Atenafu EG, et al: Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J 2014; 43: 817-823.
51. Conway S, Balfour-Lynn IM, De Rijcke K, et al: European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre. J Cyst Fibros 2014; 13(suppl 1):S3-S22.
52. Wheatley CM, Wilkins BW, Snyder EM: Exercise is medicine in cystic fibrosis. Exerc Sport Sci Rev 2011; 39: 155-160.
53. Stevens D, Oades PJ, Armstrong N, et al: A survey of exercise testing and training in UK cystic fibrosis clinics. J Cyst Fibros 2010; 9: 302-306.
54. Barker M, Hebestreit A, Gruber W, et al: Exercise testing and training in German CF centers. Pediatr Pulmonol 2004; 37: 351-355.
55. Cox NS, Elkins MR: Physical training has several benefits for people with cystic fibrosis. Br J Sports Med 2011; 45: 835-836.
56. Selvadurai HC, Blimkie CJ, Meyers N, et al: Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002; 33: 194-200.
57. Klijn PH, Oudshoorn A, van der Ent CK, et al: Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004; 125: 1299-1305.
58. Kriemler S, Kieser S, Junge S, et al: Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial. J Cyst Fibros 2013; 12: 714-720.
59. Schneiderman-Walker J, Pollock SL, Corey M, et al: A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr 2000; 136: 304-310.
60. Moorcroft AJ, Dodd ME, Morris J, et al: Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial. Thorax 2004; 59: 1074-1080.
61. Hebestreit H, Kieser S, Junge S, et al: Longterm effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J 2010; 35: 578-583.
62. Rovedder PM, Flores J, Ziegler B, et al: Exercise programme in patients with cystic fibrosis: a randomized controlled trial. Respir Med 2014; 108: 1134-1140.
63. Houston BW, Mills N, Solis-Moya A: Inspiratory muscle training for cystic fibrosis. Cochrane Database Syst Rev 2013; 11:CD006112.
64. Newall C, Stockley RA, Hill SL: Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005; 60: 943-948.
65. Mandal P, Sidhu MK, Kope L, et al: A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Respir Med 2012; 106: 1647-1654.
66. van ZellerM, Mota PC, Amorim A, et al: Pulmonary rehabilitation in patients with bronchiectasis: pulmonary function, arterial blood gases, and the 6-minute walk test. J Cardiopulm Rehabil Prev 2012; 32: 278-283.
67. Moran F, Bradley J: Incorporating exercise into the routine care of individuals with cystic fibrosis: is the time right? Expert Rev Respir Med 2010; 4: 139-142.
68. Saiman L, Siegel JD, LiPuma JJ, et al: Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014; 35(suppl 1):S1-S67.
69. Silverman M, Hobbs FD, Gordon IR, et al: Cystic fibrosis, atopy, and airways lability. Arch Dis Child 1978; 53: 873-877.
70. Kaplan TA, Moccia G, McKey RM Jr: Unique pattern of pulmonary function after exercise in patients with cystic fibrosis. Pediatr Exerc Sci 1994; 6: 275-286.
71. Macfarlane PI, Heaf D: Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis. Pediatr Pulmonol 1990; 8: 4-11.
72. Konstan MW, Doring G, Heltshe SL, et al: A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis. J Cyst Fibros 2014; 13: 148-155.
73. Lebecque P, Lapierre JG, Lamarre A, et al: Diffusion capacity and oxygen desaturation effects on exercise in patients with cystic fibrosis. Chest 1987; 91: 693-697.
74. Ruf K, Hebestreit H: Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis. J Cyst Fibros 2009; 8: 83-90.
75. Ferrand RA, Desai SR, Hopkins C, et al: Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis 2012; 55: 145-152.
76. Boas SR: Exercise recommendations for individuals with cystic fibrosis. Sports Med 1997; 24: 17-37.
77. Flume PA, Strange C, Ye X, et al: Pneumothorax in cystic fibrosis. Chest 2005; 128: 720-728.
78. Ruf K, Winkler B, Hebestreit A, et al: Risks associated with exercise testing and sports participation in cystic fibrosis. J Cyst Fibros 2010; 9: 339-345.
79. Flume PA, Mogayzel PJ Jr, Robinson KA, et al: Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182: 298-306.
80. Hebestreit H: Exercise in cystic fibrosis; in Mall MA, Elborn JS (eds): Cystic Fibrosis. Sheffield, European Respiratory Society, 2014, pp 203-218.
81. Flume PA, Yankaskas JR, Ebeling M, et al: Massive hemoptysis in cystic fibrosis. Chest 2005; 128: 729-738.
82. Albert RK, Schuller JL: Macrolide antibiotics and the risk of cardiac arrhythmias. Am J Respir Crit Care Med 2014; 189: 1173-1180.
83. Sermet-Gaudelus I, Castanet M, Retsch-Bogart G, et al: Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev 2009; 10: 134-142.
84. Baris S, Ozen A, Ercan H, et al: Osteoporosis: an ignored complication of CVID. Pediatr Allergy Immunol 2011; 22: 676-683.
85. Bar-Or O, Blimkie CJ, Hay JA, et al: Voluntary dehydration and heat intolerance in cystic fibrosis. Lancet 1992; 339: 696-699.
86. Moran A, Brunzell C, Cohen RC, et al: Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33: 2697-2708.
87. Frier BM: Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol 2014; 10: 711-722.
88. Cox NS, Alison JA, Holland AE: Interventions for promoting physical activity in people with cystic fibrosis. Cochrane Database Syst Rev 2013; 12:CD009448.
89. Baldwin DR, Hill AL, Peckham DG, et al: Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis. Respir Med 1994; 88: 49-53.
90. Sutton PP: Chest physiotherapy: time for reappraisal. Br J Dis Chest 1988; 82: 127-137.
91. van de Weert-van Leeuwen PB, Arets HG, van der Ent CK, et al: Infection, inflammation and exercise in cystic fibrosis. Respir Res 2013; 14: 32.
92. Cholewa JM, Paolone VJ: Influence of exercise on airway epithelia in cystic fibrosis: a review. Med Sci Sports Exerc 2012; 44: 1219-1226.
93. Myers LB: An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis. J Cyst Fibros 2009; 8: 425-427.
94. Sawicki GS, Sellers DE, Robinson WM: High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009; 8: 91-96.
95. Swisher AK, Erickson M: Perceptions of physical activity in a group of adolescents with cystic fibrosis. Cardiopulm Phys Ther J 2008; 19: 107-113.
96. Happ MB, Hoffman LA, Higgins LW, et al: Parent and child perceptions of a self-regulated, home-based exercise program for children with cystic fibrosis. Nurs Res 2013; 62: 305-314.
97. Bravata DM, Smith-Spangler C, Sundaram V, et al: Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007; 298: 2296-2304.
98. Kuys SS, Hall K, Peasey M, et al: Gaming console exercise and cycle or treadmill exercise provide similar cardiovascular demand in adults with cystic fibrosis: a randomised cross-over trial. J Physiother 2011; 57: 35-40.
99. Holmes H, Wood J, Jenkins S, et al: Xbox Kinect represents high intensity exercise for adults with cystic fibrosis. J Cyst Fibros 2013; 12: 604-608.